The Electronic Journal of Biotechnology is a premier Open Access journal published by Pontificia Universidad Catolica de Valparaiso, Chile, dedicated to advancing the fields of applied microbiology and biotechnology. With its inception in 1998 and an unwavering commitment to sharing knowledge, the journal has garnered a respectable ranking within the Q3 quartile for both its biotechnology and applied microbiology categories as of 2023, reflecting its significance in the academic community. Researchers and professionals will find its editorial rigor complemented by a robust platform for disseminating innovative findings, fostering collaboration, and driving forward biotechnology discussions. Given its inclusive approach, having transitioned to Open Access in 2014, the journal ensures that research is accessible to a global audience, making it a valuable resource for students, academics, and industry practitioners alike. Through the publication of original research, reviews, and critical insights, the Electronic Journal of Biotechnology aims to bridge the gap between scientific discovery and practical application, ultimately contributing to advancements in health, agriculture, and environmental sustainability.

AMB Express is an esteemed open-access journal published by Springer, dedicated to the fields of Applied Microbiology and Biotechnology as well as Biophysics. Since its inception in 2011, the journal has played a pivotal role in disseminating cutting-edge research and advancements, particularly for the scientific community in Germany and beyond. With a notable impact factor and ranking in the top quartile of its categories, AMB Express is recognized for its contributions to the disciplines, ranking 29th in Biochemistry, Genetics and Molecular Biology and 37th in Applied Microbiology and Biotechnology, reflecting its commitment to high-quality scientific inquiry. Researchers, professionals, and students will find a wealth of knowledge within its pages, benefiting from a diverse array of articles that stimulate innovation and collaboration. As the journal continues its convergence from 2011 to 2024, it remains a vital source for anybody looking to stay at the forefront of microbiological and biotechnological studies.

3 Biotech is a prestigious interdisciplinary journal, published by SPRINGER HEIDELBERG, focusing on the evolving fields of biotechnology, agricultural and biological sciences, and environmental science. With an impressive impact factor and categorized in Q2 across multiple fields in the 2023 rankings, this journal stands out for its contribution to innovative research and its commitment to advancing scientific understanding. Featuring rigorous peer-reviewed articles, it serves as a vital resource for researchers, professionals, and students alike, further enhanced by its significant presence in Scopus rankings. This journal facilitates open discussions and collaborative efforts, aiming to bridge the gap between theoretical research and practical applications in biotechnology. As it continues to publish impactful studies from 2011 to 2024, 3 Biotech is dedicated to shaping the future of biosciences and fostering meaningful scientific advancements.

New Biotechnology, published by Elsevier, is a distinguished academic journal focused on the innovative realms of biotechnology and bioengineering. With an impact factor reflecting its strong presence in the field, this journal serves as a vital resource for researchers and professionals in the life sciences, offering insights into cutting-edge advancements and applications in biotechnology, molecular biology, and related disciplines. The journal's open access policy enhances its accessibility, allowing broad dissemination of knowledge and research findings. With a robust set of Scopus ranks placing it in the top tiers of its categories, including rank #36 in Biotechnology and #24 in Bioengineering, New Biotechnology represents a critical platform for scholars aiming to contribute to the ongoing dialogue in these rapidly evolving fields. Since its inception in 2008 and continuing through to 2024, the journal remains committed to fostering innovation and collaboration among scientists dedicated to advancing biotechnological applications, thereby significantly impacting medicine and industry.

JOURNAL OF INDUSTRIAL MICROBIOLOGY & BIOTECHNOLOGY, published by Oxford University Press, is a vital resource for researchers and professionals actively engaged in the fields of applied microbiology, biotechnology, and bioengineering. With an ISSN of 1367-5435 and E-ISSN of 1476-5535, this journal has established itself as a leading platform for disseminating innovative research findings and advancing knowledge in industrial microbiology since its inception in 1996. As of 2023, it is classified in the Q2 quartile across multiple categories including Applied Microbiology and Biotechnology, Bioengineering, and Medicine, underscoring its significance in the academic community. Notably, it ranks 26th of 127 in Applied Microbiology and Biotechnology, placing it in the 79th percentile, indicative of its high impact and influence. Although it does not currently offer Open Access, it remains a key outlet for high-quality scholarly articles that align with the objectives of improving industrial practices through biotechnological applications. For those interested in the latest developments and methodologies within the realm of applied microbiology and biotechnology, this journal serves as an indispensable reference.

Applied Biological Chemistry, published by SPRINGER SINGAPORE PTE LTD, is a premier open access journal that has been serving the biological sciences community since 2016. With an ISSN of 2468-0834 and E-ISSN of 2468-0842, this journal is committed to disseminating high-quality research in the fields of Biochemistry, Genetics, Molecular Biology, and Organic Chemistry. The journal holds a commendable position within the scientific community, ranking in the Q2 quartile for both Biochemistry and Organic Chemistry niches as of 2023. It aims to foster innovative research and facilitate discussions that propel the understanding of complex biochemical processes and molecular techniques. By providing open access to its contents, Applied Biological Chemistry ensures that valuable research is readily available to researchers, professionals, and students globally, encouraging collaboration and knowledge sharing in this rapidly evolving discipline. Its pivotal role in enhancing scientific communication in the Netherlands and beyond is further underscored by a steadily increasing impact in the academic arena.

ENZYME AND MICROBIAL TECHNOLOGY, a premier journal published by Elsevier Science Inc, serves as a pivotal platform for researchers and professionals dedicated to exploring the dynamic intersections of microbiology, biochemistry, and bioengineering. With a rich publication history dating back to 1979 and converging until 2024, this journal has established itself within the Q2 quartile rankings across multiple categories, including Applied Microbiology and Biotechnology, Biochemistry, Bioengineering, and Biotechnology, highlighting its influential role in advancing scientific discourse. It holds impressive Scopus rankings, where it is recognized in the 79th percentile for Applied Microbiology and Biotechnology and ranks favorably in related fields, making it a valuable resource for academic and industrial researchers looking to stay abreast of the latest developments. Although it does not currently offer Open Access options, ENZYME AND MICROBIAL TECHNOLOGY remains an essential read for anyone invested in the biotechnological applications of enzymes and microorganisms.

TRENDS IN BIOTECHNOLOGY, published by CELL PRESS, stands as a premier journal since its inception in 1983, focusing on the dynamic and ever-evolving fields of bioengineering and biotechnology. With a notable impact factor and ranking in the top quartile (Q1) of its categories for 2023, this journal is recognized for its contribution to advancing scientific knowledge, boasting a Scopus rank of #5/311 in Biotechnology and #5/162 in Bioengineering, placing it in the 98th and 97th percentiles, respectively. Although it does not operate under an open access model, TRENDS IN BIOTECHNOLOGY ensures a rigorous peer-review process that provides a platform for high-quality research that influences both academic and industrial advancements. The journal's objectives encompass the dissemination of cutting-edge research findings, reviews, and insights that foster innovation in biotechnological applications, making it an invaluable resource for researchers, professionals, and students alike. With its broad scope across the intersection of biosciences and technology, TRENDS IN BIOTECHNOLOGY continues to lead discussions and developments that shape the future of the biotechnology landscape.

MOLECULAR BIOTECHNOLOGY, published by SPRINGERNATURE, is a pivotal journal in the fields of applied microbiology, molecular biology, biochemistry, and biotechnology. Since its inception in 1994, the journal has aimed to disseminate high-quality research that explores the intersection of molecular biology and technology, fostering advancements in biotechnology applications. With an ISSN of 1073-6085 and an E-ISSN of 1559-0305, it has established itself as a significant contributor to the scientific community, currently holding a Q3 ranking across multiple categories including Applied Microbiology & Biotechnology and Biochemistry in the 2023 metrics. Although not an open access publication, the journal remains accessible through various institutional subscriptions, providing valuable insights and findings to researchers and professionals. Given its ongoing commitment to quality and relevance, MOLECULAR BIOTECHNOLOGY serves as an essential resource for those involved in cutting-edge research and innovation in molecular biotechnology and related disciplines.

Current Research in Biotechnology is a leading journal published by Elsevier, dedicated to the dissemination of high-quality research in the rapidly evolving field of biotechnology. With an ISSN of 2590-2628, this journal has garnered a reputation for its insightful contributions, currently holding a prestigious Q2 ranking in the Biotechnology category, and placing in the 66th percentile within the Scopus rankings for Biochemistry, Genetics, and Molecular Biology. Running from 2019 and set to continue through 2024, the journal aims to provide a platform for groundbreaking studies that advance our understanding and application of biotechnological innovations. Although it operates under a subscription model, the journal ensures that research impacts a wide audience, facilitating collaboration among researchers, professionals, and students across the globe. By focusing on a diverse range of topics within biotechnology, Current Research in Biotechnology is committed to cultivating a vibrant discourse and fostering advancements that address critical challenges in health, agriculture, and environmental sustainability.